TREND IN PREVALENCE AND DISTRIBUTION OF DIABETES MELLITUS TYPE I AND TYPE II IN THE NETHERLANDS

Author(s)

Overbeek JA¹, Penning FJ¹, van Dongen E², Herings RM¹
¹PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands, ²Novo Nordisk B.V., Alphen a/d Rijn, The Netherlands

Presentation Documents

PDB30--strong-u-overbeek-ja-u-sup-1-sup-strong-penning-fj-sup-1-sup-van-dongen-e-sup-2-sup-herings-rm-sup-1-sup-br-sup-1-sup-pharmo-institute-for-drug-outcomes-research-utrecht-the-netherlands-sup-2-sup-novo-nordisk-b-v-alphen-a-d-rijn-the- ...

OBJECTIVES: To quantify the trend in prevalence and distribution of diabetes mellitus (DM) type I (T1DM) and type II (T2DM) in the Netherlands

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PDB30

Topic

Epidemiology & Public Health

Disease

Diabetes/Endocrine/Metabolic Disorders

Presentation